HOME >> BIOLOGY >> NEWS
Surveillance and containment would be effective intervention against deliberate smallpox attack

SEATTLE -- In the event of a large, intentional release of smallpox, the current government policy of post-release surveillance and containment, if quickly implemented, would be sufficient to prevent a widespread epidemic, according to a study by biostatisticians at Emory University's Rollins School of Public Health. Surveillance and containment consist of isolating known cases and vaccinating close contacts.

Delays in isolating cases by even one or two days, however, could hamper control of an epidemic, according to research by Ira M. Longini, Jr., PhD and M. Elizabeth Halloran, MD, Sc, Emory professors of biostatistics and their colleagues Azhar Nizam and Yang Yang, Dr. Longini will present the research at the AAAS Annual Meeting in Seattle on February 14.

Although mass vaccination during or before a smallpox attack would result in fewer cases and deaths than would surveillance and containment, the researchers concluded that an increased rate of vaccine-related serious illness and death would offset the slightly lower number of smallpox illnesses and deaths, especially since no one knows when or where an intentional release of smallpox would take place. The scientists also concluded that even if a particular smallpox virus were altered to cause more serious, or hemorrhagic cases than the ordinary virus, surveillance and containment would still be effective, although more deaths would occur.

In an earlier study (Science, Nov. 15 2002), the researchers concluded that targeted vaccination of the close contacts of infected individuals during a smallpox outbreak following a small attack could rival the effectiveness of mass vaccination, given a sufficiently high level of immunity within the population. However, as of May, 2003, fewer than 35,000 people had been newly vaccinated against smallpox, and many states had temporarily halted their smallpox vaccination programs. Although routine smallpox vaccinations were stopped in 1972, re
'"/>

Contact: Tia Webster
twebste@emory.edu
404-727-5692
Emory University Health Sciences Center
14-Feb-2004


Page: 1 2 3

Related biology news :

1. Protecting the Beat Of Life: Test Center Studies Interaction Between Pacemakers & Electronic Article Surveillance Systems
2. Hopkins Engineering Undergrads Inventions: Power Tools For Double Amputee, Military Surveillance Robot
3. Conserving hydrocarbons would save $438 billion
4. Sediment samples suggest how plants would fare in hotter, drier future
5. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
6. Endurance exercise found to be equally effective as diuretics in improving cardiac health
7. Purdue yeast makes ethanol from agricultural waste more effectively
8. Scientists learn how adjuvant makes vaccines effective
9. Super-effective jumping gene created
10. Drug combo effective in advanced breast cancer
11. Data show investigational antibiotic safe, effective in preventing travelers diarrhea

Post Your Comments:
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... Menlo Park, CA (PRWEB) December 17, 2014 ... Inc. announces today that it has entered into ... Daniels Midland Company (ADM) to apply DNA2.0’s proprietary ... industrial enzyme engineering process. , “We are extremely ... our ProteinGPS engineering platform. This proprietary bioengineering ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: